Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$1,452 Mln
Revenue (TTM)
$912 Mln
Net Profit (TTM)
$0 Mln
ROE
0.2 %
ROCE
-- %
P/E Ratio
10.3
P/B Ratio
1.8
Industry P/E
--
EV/EBITDA
14.6
Div. Yield
0 %
Debt to Equity
0
Book Value
$26.7
EPS
$5
Face value
--
Shares outstanding
28,797,307
CFO
$-144.48 Mln
EBITDA
$-279.53 Mln
Net Profit
$-277.73 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Inspire Medical Systems (INSP)
| -40.4 | -14.8 | -40.4 | -65.2 | -38.3 | -23.4 | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Inspire Medical Systems (INSP)
| -50.2 | -8.8 | -19.2 | 9.5 | 22.3 | 153.5 | 75.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Inspire Medical Systems (INSP)
|
55.0 | 1,451.7 | 912.0 | 145.4 | 6.1 | 19.8 | 10.3 | 1.8 |
| 7.9 | 5,176.8 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 0.9 | |
| 36.8 | 5,222.6 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.1 | |
| 25.8 | 3,989.0 | 2,719.5 | 47.0 | 8.4 | 1.6 | 86.6 | 1.3 | |
| 112.8 | 6,098.9 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 8.9 | |
| 76.1 | 4,758.4 | 1,541.6 | 233.6 | 21.6 | 21.4 | 21.4 | 4.5 | |
| 178.6 | 9,411.8 | 1,526.9 | -151.5 | 20.0 | -17.1 | -- | 12.9 | |
| 330.4 | 12,879.6 | 1,403.7 | 177.7 | 14.7 | 13.8 | 72.5 | 9.2 | |
| 117.8 | 6,280.4 | 738.3 | 48.9 | 11.4 | 2.4 | 129.6 | 3.0 | |
| 32.1 | 13,409.8 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.1 | 2.6 |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers... Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. Address: 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416 Read more
CEO, President & Director
Mr. Timothy P. Herbert
Founder, Chairman, CEO & President
Mr. Timothy P. Herbert
Headquarters
Golden Valley, MN
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Inspire Medical Systems Inc (INSP) is $54.99 (NYSE) as of 02-Apr-2026 16:28 EDT. Inspire Medical Systems Inc (INSP) has given a return of -38.3% in the last 3 years.
The P/E ratio of Inspire Medical Systems Inc (INSP) is 10.31 times as on 31-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
18.53
|
3.45
|
|
2024
|
106.54
|
8.27
|
|
2023
|
-290.79
|
10.74
|
|
2022
|
-169.54
|
15.34
|
|
2021
|
-149.80
|
27.50
|
The 52-week high and low of Inspire Medical Systems Inc (INSP) are Rs 164.02 and Rs 48.30 as of 03-Apr-2026.
Inspire Medical Systems Inc (INSP) has a market capitalisation of $ 1,452 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Inspire Medical Systems Inc (INSP), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$1.35
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.